Dupuytren Disease




Dupuytren disease (DD) is the most common heritable disorder affecting connective tissues. It is an inherited, benign, chronic progressive condition that results in fibrotic changes of the palmar and digital fascia and adjacent soft tissues. DD causes tissues to shorten along lines of mechanical tension, limiting digit extension. Dupuytren contracture (DC) is the end result of DD. There is not yet an effective treatment for DD. Primary treatment options for DC range from soft tissue release (i.e., collagenase injection, open or percutaneous needle fasciotomy) to excision (i.e., fasciectomy, dermofasciectomy). Because current treatments address only the contracture not its cause, both recurrence (reappearance of clinical disease in a treated area) and extension (posttreatment appearance of disease in untreated areas) are common.


Treatment of both primary and recurrent disease should be individualized, based on a person’s risk factors and disease history. Treatment is empiric, and many aspects of DD lack clarity: enigmatic biology; unpredictable natural history; lack of standard terminology either for severity, outcome, recurrence, or patient satisfaction; lack of an animal model; lack of a unique biomarker; variation in biologic aggressiveness; or slow progression, often over the course of years. Proper management can be very rewarding, and treatment options have grown in the last decade, yet “… two issues remain unsolved relevant to Dupuytren’s disease: its cause and its cure.”


Demographics


DD has the highest prevalence in senior Caucasian men with blue or green eyes who have a family history of the condition. DD is uncommon in those under the age of 40, but prevalence increases with age, as shown in Figure 4.1 . Mean prevalence in Western countries is 12% at age 55, 21% at age 65, and 29% at age 75. Pediatric DD has been reported sporadically, but the diagnosis cannot be confirmed with certainty because of a lack of a unique biomarker. The most common age range at diagnosis is early fifties to early sixties. Incidence in women parallels that of men, but lags by an average of 10 to 15 years, resulting in a male : female prevalence ratio that decreases with age.




FIGURE 4.1


Summary of Dupuytren disease prevalence data in 11 high-quality studies selected from 199 reviewed publications. Lines represent mean values; shaded areas are 95% confidence intervals. Prevalence in women parallels that of men, but lags by about 15 years.


Some studies have reported that prevalence in men decreases after the age of 70 and in women after the age of 80, thought to reflect attrition from increased mortality rates of patients with DD compared to the general population, as well as higher mortality rates of men compared to women in the general population. The average patient has two or three affected rays; the ring or little finger are most commonly involved. Overall, half of patients have bilateral disease, but this varies with age; DD presents bilaterally in only 20% of patients, but over time increases to at least 70%. The overall prevalence of Dupuytren contracture accounts for less than one-fifth of all patients with Dupuytren disease.


Clinical behavior stratifies patients into four biologic groups. In order of increasing risk of needing future treatment for DC, these groups are those without clinical DD, those with DD but no contracture, those with untreated DC, and those with treated DC. Unfortunately, because diagnostic codes prior to the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) did not differentiate Dupuytren disease from contracture , data for these groups have often been mingled.


Heritability


Inheritance patterns of DD appear to follow an autosomal dominant pattern with variable penetrance. Despite reports of a northern European concentration, recent studies suggest that it is common in Caucasians in general, common throughout Europe and less common in Asia, as shown in Figure 4.2 . Definitive prevalence data are lacking from Africa, Russia, India, and China. African Americans have just less than one-fifth the prevalence of Caucasian Americans, similar to the average percent Caucasian heritage of African Americans. Hispanic Americans have one-third and Asian Americans one-tenth the prevalence of Caucasian Americans. Prevalence reported in family history studies is often underestimated because of the combination of late onset and lack of awareness of mild involvement in senior relatives. Nearly half of patients with DD have a relative who is known to have the disease.




FIGURE 4.2


Prevalence of Dupuytren disease in men reported in studies from five different countries. In these, prevalence in northern and southern Europe is similar; both are greater than the incidence in Japan.


Positive family history is the single strongest predictor of the disease and is associated with both earlier age of onset and earlier age of first treatment. A family history involving both parents is associated with younger age of onset than a history of only one affected parent. An affected sibling triples one’s risk of developing DD. Although these findings strongly suggest a genetic basis, a specific locus has yet to be identified. It is not clear whether DD is one condition or, like diabetes, the common destination of several different starting points.


Associated Conditions


DD has been associated with comorbidities including hypercholesterolemia, diabetes, smoking tobacco, excessive alcohol use, epilepsy, antiepileptic medication, regional trauma, chronic heavy manual labor, and a lower-than-average body mass index. The literature is far from clear on this topic and lack of association has also been reported for each of these factors. False association bias with other medical disorders may exist in that DD is more likely to be diagnosed in patients who have more medical office visits for other conditions. The volume of evidence suggests that these conditions are probably associated but not causative of DD.




Genetic Biomarkers


Efforts to characterize gene expression associated with disease activity have identified cellular regulatory abnormalities associated with DD. Dupuytren tissue is not a monoclonal neoplastic process. The largest genome-wide association study to date identified nine genetic loci associated with genetic susceptibility to DD. Genetic markers specific to DD have been identified in profibrotic pathways involving regulation of transforming growth factor beta one (TGFβ1); cell differentiation; proliferation and apoptosis ; metalloproteinase activity ; fibroblast growth factor ; vascular endothelial growth factor ; hypoxia inducible factor alpha ; and, in particular, proteins in the Wnt-signaling pathway. HLA studies have identified an increased incidence of HLA-DRB1*01 genotype in Caucasians with DD, and HLA-B7 haplotype in both Peyronie disease and DD.


DD gene expression studies face many challenges. The physical setup of cell culture affects gene expression and cytokine response and may not replicate the mechanical environment that influences gene expression in vivo. The site of tissue origin affects mechanoregulation of gene expression in otherwise similar tissues. Finally, the genetic relationship of DD and gender is complex: palmar fascia has overexpression of androgen receptors ; TIMP-1 , the gene that expresses tissue inhibitor of metalloproteinase 1 (a collagenase implicated in DD), is located on the X-chromosome ; estrogen suppresses both collagen synthesis and matrix metalloproteinase gene expression in response to acute mechanical stress. Compared to men, incidence in women is delayed until after the average age of menopause.




Preoperative Evaluation


Physical Examination


Early Dupuytren disease is commonly overlooked and underreported. The earliest signs of Dupuytren disease takes the form of skin tightness (i.e., exaggerated blanching with finger extension), contour changes (i.e., skin crease deformation, dimples), nodules, cords without contractures, or prominence of the palmar monticuli, as shown in Figure 4.3 . Nodules are the first change noticed by about 6 out of 10 patients. Nodules are flattened round or ovoid areas of subdermal firmness, fixed to the dermis, typically 0.5 to 1.5 cm in diameter with indistinct peripheral margins. The dermal papillae overlying nodules may be prominent or may be longitudinally compressed, different from the type of papillary ridge stretching and flattening seen with other slowly growing tumors ( Figure 4.4 ). Uncommonly, nodules are initially erythematous, tender, or itchy. Skin crease deformation or dimples are the first change noticed in about 1 out of 10 patients.




FIGURE 4.3


Earliest signs of Dupuytren disease in patients with Dupuytren contracture on the opposite hand. A, Palmar skin tightness, blanching in the digits with neutral extension; B, dimpling of the lateral digit; C, prominence of the interdigital palmar monticuli in the distal palm from central band tightness. This hand also demonstrates a ring finger nodule with adjacent distal skin retraction.



FIGURE 4.4


This patient has diffuse nodular skin involvement of Dupuytren disease, but no contractures. The dermal papillae are abnormally prominent over the nodules of the middle and ring rays, almost resembling fingerprints. Dimples and nodules are also visible at the base of the index finger and thumb as well as the first-web space.


Dorsal Dupuytren nodules (DDN), also called Garrod pads or knuckle pads , are firm masses on the extensor aspect of the digital joints, and histologically resemble palmar nodules ( Figure 4.5 ). DDN most commonly affect the proximal interphalangeal (PIP) joints, but occasionally the distal interphalangeal (DIP), metacarpophalangeal (MCP), or interphalangeal (IP) joint of the thumb, or rarely the extensor mechanism. DDN are fixed to the superficial paratenon of the extensor mechanism and involve overlying subcutaneous tissue and retinacular fibers to a variable degree. Secondary skin involvement may occur. DDN can be confused with dorsal cutaneous pads : local dorsal joint skin thickening and hyperkeratosis that only involves the skin. DDN are found in one in five DD patients, often precede palmar DD, and are associated with more aggressive biology.




FIGURE 4.5


Variations of dorsal Dupuytren nodules. A, No skin involvement; B, dimpling with or without nodule; C, prominence over the condyles; D, inflammatory with diffuse skin tethering.


In contrast, dorsal cutaneous pads are not associated with Dupuytren disease and are equally common with and without DD. Occasionally, the earliest sign of a DDN is a tethered depression of the extensor skin creases (see Figure 4.5 ). Palpated cords feel like strings beneath the skin, and vary from a few millimeters to greater than a centimeter in width. Although they may be found independent of each other, nodules and cords are usually arranged as beads on a string. Nonnodular cords, unlike nodules, feel firm only when placed under tension, have well-defined margins, and are not fixed to the dermis. There is often overlap of nodules and cords ; that is, nodular cords share nodular aspects of dermal adherence and firmness unrelated to joint position. All of these early changes may go unnoticed by the patient.


It is likely that the majority of patients with only mild Dupuytren disease will not progress to Dupuytren contracture. Reilly followed patients who initially presented with only nodules. At an average of nearly 9 years, about 1 in 10 had progressed to contracture; 1 in 10 had nodule regression; 4 in 10 had progressed to cord without contracture; and 4 in 10 had neither progressed nor regressed. Gudmundsson reported that almost two-thirds of 75 patients presenting with a nodule or cord without contracture did not progress to contracture over an 18-year period of observation. Conversely, patients may develop contractures without noticing nodules: cords or contractures are the sentinel finding in nearly one-quarter of patients.


Because the diagnosis is made by clinical examination, the differential diagnosis of palmar nodules also includes fibrosarcoma, fibrous histiocytoma, giant cell tumor, synovial sarcoma, calcifying aponeurotic fibroma, epithelioid sarcoma, and other less common tumors. For this reason, the patient presenting with an isolated palmar mass diagnosed as DD should be seen for scheduled follow-up to confirm that the mass does not undergo unexpected changes.


The earliest appearance of Dupuytren contracture is passive extension deficit due to a contracted cord, most often affecting the MCP and PIP joints of the fingers. Almost all cords can be palpated with fingertip pressure. Because nonnodular cords feel firm only when under tension, the key to cord palpation is to feel for a change from soft to firm as the finger is passively ranged from flexion to extension. Most cords develop along recognizable lines of mechanical tension produced by passive extension or abduction. Patients with aggressive Dupuytren biology or who have had prior treatment are more likely to vary from these common patterns.


Cords may result in isolated flexion contractures of the MCP, PIP, or DIP joints or combinations of these. Thumb involvement may result in carpometacarpal (CMC) MCP or IP flexion contractures and/or radial or palmar adduction contractures. Natatory ligament contractures that adduct the fingers may be masked by the adducting effect of MCP joint contractures. Contractures on the ulnar border of the palm may produce little finger MCP flexion/abduction contractures.


Staging


There is no universally accepted system for either describing the quality or quantifying the severity of DC. Objective multifactorial tests, such as the Sollerman test and Rosenbloom joint mobility assessment, and other measures have been used for evaluation of DD but are not disease-specific. Because DC is usually painless, the inclusion of pain questions dilutes the value of subjective tests such as the Disabilities of the Arm, Shoulder, and Hand (DASH) and Michigan Hand Outcomes (MHQ); neither correlate well with range-of-motion mea­surements. Range-of-motion measurements are the most common assessment, but often cannot be compared because of incompatible formats such as individual versus multiple joints, active versus passive measurements, and other author-defined measures. Range-of-motion measurements alone do not correlate well with hand function.


Other systems exist, incorporating grip strength, flexion deficit, sensibility, scarring, improvement, satisfaction, and other measures specific to postoperative evaluation. The Unité Rhumatologique des Affections de la Main scale (URAM) questionnaire and Southampton Dupuytren’s Scoring System (SDSS) have been developed as disease-specific staging systems, but neither has yet gained wide adoption. Each of the following subsections focuses on common classification schemes for a specific portion of the overall picture.


Luck Classification and Related Histology


Luck described a progression of three histologic stages: proliferative , involutional , and residual, roughly corresponding to nodules, nodular cords, and nonnodular cords, respectively. The key cell is the myofibroblast , which under light microscopy resembles a fibroblast but has ultrastructural differences: stress fibers, cell membrane adhesion complexes, fibronectin fibers, smooth muscle α-actin, and other unique characteristics. The proliferative cellular stage is characterized by highly cellular, mitotic histology with randomly oriented myofibroblasts and sparse, randomly oriented collagen fibrils. Specimens of the involutional fibrocellular stage are less cellular with no mitoses, and show some parallel orientation of myofibroblasts and collagen fibrils. Residual fibrotic stage histology is characterized by relatively acellular collagen with flattened cells within areas of uniformly oriented densely packed collagen bundles. Occluded microvessels and basal lamina thickening are also present in cords, nodules, and perinodular areas.


Luck staging correlates with collagen type. Normal palmar fascia has little or no type III collagen. Abnormally high levels of type III collagen exist in the palmar fascia of DD patients even in the absence of contracture. The ratio of type III to type I collagen is highest in the proliferative stage (>35%). This ratio decreases to the range of 20 to 35% in involutional specimens, and to less than 20% in residual specimens. Type III collagen persists in affected tissues: the involutional stage is static, but not normal.


Luck staging correlates with recurrence rate after fasciectomy. Balaguer et al analyzed outcomes at 8 to 9 years after fasciectomy and reported that proliferative histology more than doubled recurrence compared to involutional histology and more than tripled recurrence compared to residual histology. This Luck stage parallels clinical assessment of nodularity and may prove applicable for preoperative recurrence prediction or for procedures performed without tissue sampling.


Tubiana Staging


The Tubiana stage is an index of composite flexion contracture. The composite MCP + PIP joint flexion contracture of each ray is placed in a group of 45-degree increments:




  • Stage 0: no contracture



  • Stage 1: 0 to 45 degrees



  • Stage 2: 45 to 90 degrees



  • Stage 3: 90 to 135 degrees



  • Stage 4: greater than 135 degrees

DIP joint angles are not included.


This classification has been modified to include notations for the presence of nodules or distal IP hyperextension for each ray, and a summary number for the entire hand as well as other notations ; however, the most common use is as a quick descriptor—the stage number of the affected finger. This classification has the unique advantage of summarizing contractures from cords that span both MCP and PIP joints and complements individual joint measurements. A variation of the Tubiana stage is the total contracture index (TCI), which is the composite MCP + PIP flexion contracture in degrees.


Individual Joint Measurements


Range-of-motion measurement of individual joints using a goniometer might seem to be the most objective documentation. However, two DD-specific issues can result in a pattern of bias affecting individual joint measurements. First, limited joint motion from Dupuytren cords may produce static or dynamic contractures. Cords spanning sequential joints produce dynamic contractures via fasciodesis: measurements at one joint are linked to the position of the adjacent spanned joint. Grotesman found dynamic contractures in more than one-third of rays having combined MCP + PIP contractures, primarily affecting a PIP joint.


This is consistent with the report of correction of untreated PIP contractures in more than one-third of combined MCP + PIP contractures in which only the MCP joint was treated with collagenase clostridium histolyticum (CCH) injection. Cords extending to the proximal palm are affected by CMC joint position, which cannot easily be measured and can affect both MCP and PIP joint measurements in a zigzag fashion ( Figure 4.6 ). Second, although cords themselves are inelastic, they arise from soft tissues that have elastic attachments: passive range-of-motion measurements are subject to examiner bias from the force applied to the finger.




FIGURE 4.6


Demonstration of dynamic contractures with carpometacarpal (CMC) fasciodesis. A, Patients use a trick motion to compensate for tight fascia, flexing their ring and small CMC joints to allow metacarpophalangeal (MCP) extension. B, CMC flexion allows 10 degrees of active MCP hyperextension. C, When CMC flexion is blocked, active MCP extension is limited to 20 degrees, which in turn improves active proximal interphalangeal extension by 10 degrees. D, blocking CMC flexion changes passive MCP extension from 0 to 65 degrees.


Location of Disease


Although much has been written regarding the anatomical basis of cords, not all cord areas have been named, and published reports lack a precise, standard system to tag cord and nodule locations in the palm based on physical examination. A diagram developed for this purpose based on skin landmarks and common patterns of DD is shown in Figure 4.7 . Forms based on this are available at http://dupuytrens.org/research-publications/forms-for-documentation , and these allow documentation of initial evaluation disease location, joint measurements, and treatment details.




FIGURE 4.7


This diagram is based on common zones of involvement and allows standard documentation of the location of physical findings, procedures, and joint measurements. PDF versions of this as evaluation and procedure forms are available at http://dupuytrens.org/research-publications/forms-for-documentation .


Diathesis Score and Severity


Biologic severity affects the clinical course both before and after treatment. Biologic severity is reflected both in the rate of progression from diagnosis to the need for treatment and the risk of recurrence, extension, stiffness, and inflammatory reaction after treatment. Biologic severity varies greatly between individuals and is not simply contracture severity. One index of biologic severity is association with specific fibrotic conditions: that is, DDN, Peyronie, Ledderhose, frozen shoulder. Despite conflicting reports, each of these is probably associated with increased risk of DD and vice versa. Why is this?


Each of these conditions occurs where inelastic fascial structures are subjected to high peak shearing or traction forces . The author’s opinion is that there is an underlying connective tissue disorder triggered by the mechanics at each of these sites, which would explain the observed overlap of risk factors; family history of DD increases the risk both of Ledderhose and of DDN. In contrast, other fibrotic conditions, such as keloid or scleroderma, are not associated with increased DD risk and appear to have different molecular pathways.


Diathesis factors predict biologic severity. Diathesis factors include bilateral palmar disease, DDN, Ledderhose disease, positive family history, age of onset younger than 50, male gender, first ray disease, and involvement of more than two digits. There has not been full agreement on the relative importance of each, but in general, the greater the number of diathesis factors, the higher the recurrence rate after surgery. The strongest predictor of greater biologic severity is younger age of onset .


Similarly, rate of recurrence drops with greater age at the time of first treatment. Some factors, such as frozen shoulder and Peyronie disease, increase the incidence risk of DD but not the rate of recurrence after surgery. This paradox might be explained by the effect of index event bias on interpretation of recurrence data, and more clarification is needed. Diathesis factors share genetic markers. Patients with early age of onset, DDNs, and a positive family history were found to have a greater likelihood of having a high genetic risk score based on a profile of single nucleotide polymorphisms associated with DD.


Documentation of DD biologic severity should include diathesis factors: family history of DD in siblings or parents; gender; age of onset of DD; current age; age of first treatment; bilaterality of DD; number of digits involved; thumb involvement; presence of nodules; presence of DDNs; presence of Ledderhose disease; presence of Peyronie disease; and history of frozen shoulder. A high diathesis score implies three or more of these factors: age of onset younger than 50, positive family history, DDN, bilateral disease, Ledderhose.


Treatment Outcome Score


Outcome assessment is most meaningful in the context of the initial contracture. Two useful objective comparative outcome measures are the Thomine coefficient ([degrees of improvement]/[degrees of initial contracture]) and CCH success ([number of joints corrected to 5 degrees or less]/[number of treated joints]). The fact that neither adequately reflects functional change in all patients reflects the difficulty of this issue. Consider, for example, a patient with a 40-degree contracture and a patient with a 140-degree contracture. For these patients, complete correction would give the same outcome score by either measure, despite very different changes in function. A 30-degree improvement would not be considered a CCH success for either, but the first patient would likely be happier than the second. Patient satisfaction correlates poorly with range-of-motion measurements regardless. Roush and Stern reported results of surgery for recurrence in which 95% of patients were “unconditionally satisfied and stated that they would have the procedure again” despite lack of improvement in average total active motion.


Recurrence Assessment


Because recurrence is a lifetime issue, recurrence percentages are meaningless unless duration is also specified. Recurrence is most accurately described as a percent per year rate , not simply a percent, and also not an average of a broad range of follow-up intervals. Many definitions of recurrence exist. Quantitative definitions include need for repeat treatment, loss of a defined percent of initial correction, or loss of a defined number of degrees of correction. Different metrics cannot be easily compared. For example, recurrence as defined in CCH studies excludes the subset of treated patients not corrected to within 5 degrees of complete extension, a group known to have a higher recurrence rate ; this skews recurrence results favorably compared to other recurrence definitions. In addition, many published studies define recurrence qualitatively or not at all.


Not all contracture recurrence is Dupuytren recurrence. Contracture recurrence falls into three categories: early, progressive, and late ( Table 4.1 ). Early recontracture develops during the first 3 postoperative months, followed by a plateau. This pattern is not recurrent Dupuytren contracture. It is due to incomplete correction of secondary pathology at the time of treatment. Central slip laxity, oblique retinacular ligament tightness, mild PIP anterior cruciate ligament (ACL), or capsular tightness may not prevent improvement at the time of treatment, but their persistent effects result in loss of initial gains over the following weeks. Because these are static influences, their effects plateau. Progressive recontracture is a steady worsening of contracture that continues to progress after the first 3 postoperative months. This is due to inadequate treatment of primary pathology: inadequate fasciotomy/ectomy of all mechanically important cord(s).



TABLE 4.1

Patterns of Recontracture After Treatment of Dupuytren Contracture
























Type Begins Course Cause
Early 1–2 weeks posttreatment Plateau after 6–12 weeks Residual secondary pathology
Progressive 6–12 weeks posttreatment Progressive Residual primary pathology
Late After posttreatment plateau lasting 12 months or longer Progressive New disease activity (true recurrence)


Both severe contractures and diffuse disease are more likely to have multiple cords affecting the same joint, some of which may escape treatment. Residual cords with soft tissue attachments may stretch without becoming discontinuous and remain biologically active and contractile during the early postoperative period. Late recontracture develops after an initial period of stability lasting a year or more after treatment.


Similar to extension of disease after treatment, late recontracture is due to progression of new Dupuytren activity and represents true recurrence . Failure to clearly separate these groups has led to confusion regarding outcomes. The author recommends the definition of recurrence published by the international Dupuytren Delphi group: “an increase in joint contracture in any treated joint of at least 20 degrees at 1 year posttreatment compared to 6 weeks posttreatment .


Diagnostic Imaging


Diagnosis is made by physical examination. Although there are objective findings consistent with Dupuytren disease, there is neither laboratory result, imaging finding, nor a biomarker unique to DD. Plain x-rays may be helpful in determining presence and extent of degenerative joint changes or heterotopic ossification of cords. Ultrasound imaging or Doppler ultrasound examination may help identify neurovascular displacement from a spiral cord. MRI can be used to evaluate the cellularity of disease and, in theory, the Luck stage—however, it has not yet been widely adopted for this use.




Pertinent Anatomy


Normal Anatomy


DD produces progressive changes in the palmar fascia, its attachments, adjacent subcutaneous tissues, and dermis. Normal anatomy is diagrammed in Figure 4.8 .




FIGURE 4.8


Normal fascial anatomy. A, Palmar view of structures beneath skin and subcutaneous tissues of the palm and finger. B, Lateral view of the deeper structures of the distal palm and finger. C, Lateral view of the more superficial structures of the distal palm and finger. D, Axial cross sectional view of finger proximal to the proximal interphalangeal joint.


Palm


The superficial palmar fascia lies in a coronal plane deep beneath the palmar subcutaneous tissue and covers a triangular area of the central palm, the proximal corner facing directly proximal. The palmaris longus tendon, when present, terminates in continuity with the fibers of this proximal corner. From this common point, four central bands of fascia extend distally toward each of the fingers. There is no central band for the thumb. Confluent proximally, these bands separate and diverge at the distal edge of the underlying transverse retinacular ligament, each following the path of the underlying ray. At the level of the distal palmar crease, the central bands are bridged transversely by the superficial transverse palmar ligament . At the radial border of the index central band, the superficial transverse palmar ligament is in continuity with the proximal first-web-space ligament , which continues to a point roughly superficial to the radial sesamoid of the thumb MCP joint. Although the superficial transverse palmar ligament appears to lie deep beneath the central bands, fibers from the central bands pass above, below, and through it. At this level, each central band branches in the following three directions.




  • Superficial fibers track superficially to merge with vertical retinacular fibers at the undersurface of the dermis in the distal palm in areas between skin flexion creases, where nodules commonly arise.



  • Intermediate fibers split transversely into two sections, which extend toward the lateral border of the base of the digit. This track of fibers is called the spiral band because fibers track around the neurovascular bundle: proximally, they are central and superficial to the bundle; distally, lateral and deep beneath it. Neurovascular spiral bundles result from involvement of these fibers.



  • Deep fibers continue dorsally to merge with the sagittally oriented interosseous fascia and pierce the transverse MP ligament to merge with fibers of the sagittal bands of the extensor mechanism. These fibers are rarely involved in contractures.



Web Spaces


A subdermal fascial layer borders the periphery of the web spaces from thumb to little finger. Fascial fibers follow the direction of this layer. The section of this structure spanning the fingers is referred to as the natatory ligament ; its continuation across the first-web space is referred to as the distal first-web-space ligament . It crosses the thumb to join fibers of the proximal first-web-space ligament over the radial sesamoid area. Fibers from the natatory ligament extend distally at the lateral base of each finger in continuity with the Grayson ligament and the lateral digit dermis.


Digits


Contradictory descriptions exist of the digital fascia anatomy because of difficulties inherent in dissecting fascial structures in the digits : fibrous strands less than 1-mm thick follow oblique curved paths; distortion from release of skin attachments are needed for exposure; distortion when fingers preserved in flexion are later straightened for dissection. Zwanenburg et al. recently reported a clarification of anatomy, as shown earlier in Figure 4.8 . The digital neurovascular structures are circumferentially enveloped within thin layers of fascia.


The traditional name for components of this envelope dorsal to the neurovascular bundle is Cleland ligament , and the traditional name for components palmar to the neurovascular bundle is Grayson ligament . These “ligaments” are actually a loose meshwork of multiple layers of crossing oblique curved fibers. There is a common zone of origin of these fibers in continuity with the retinacular ligaments of the fingers, the floor of the flexor tendon sheath, and the network of retinacular fibers that attach to the palmar digital skin. On the ulnar border of the small finger, this pattern of lateral fascial attachments continues in continuity with the abductor digiti minimi fascia and tendon. What has been described in the digits as the retrovascular band is actually a dissection artifact created by releasing skin attachments of this lateral fascial complex.


Pathologic Anatomy


Primary Pathology


Core elements of Dupuytren biology are shared with other fibrotic diseases: myofibroblasts, collagen, cytokines, and mechanical stress on the extracellular matrix. Nodules are the most active sites of this process. Nodules arise on the palmar surface of the fascia in areas where shear forces from gripping are resisted by retinacular fibers that anchor dermis to fascia and result in local mechanical strain. Typical light microscopic changes are described in the earlier discussion of the Luck classification. The known process begins as fibroblasts in an extracellular matrix subjected to mechanical stress and in the presence of TGFβ1 differentiate into myofibroblasts.


Myofibroblast gene expression results in the appearance of new intracellular α-SMA microfilaments, large cell-matrix attachments, and intercellular junctions. Cell-matrix attachments (focal adhesions) of collagen strands to myofibroblast cell membranes signal myofibroblasts to contract in response to mechanical stress on the extracellular matrix. Individual collagen strands are folded by myofibroblast contraction, and extracellular matrix enzymes crosslink across these folds ( Figure 4.9 ).




FIGURE 4.9


Myofibroblast cycle of extracellular matrix (ECM) remodeling. Relaxed ( green lines ) and contracting ( red lines ) intracellular stress fibers are joined to extracellular collagen strands via focal adhesions ( green circles ) in the cell membrane. 1: Mechanical stress on the ECM triggers global contraction of all stress fibers. 2: This generates slack in individual collagen strands along lines of mechanical tension. 3: The slack collagen strands are repositioned by individual stress fibers, creating a loop. 4: ECM crosslinking enzymes (yellow triangle) join the base of the loop and trim the redundant strand. 5: The strand is released into the ECM. 6: The shortened strand then stress shields the stress fibers, allowing the cell to return to its prior state and repeat the cycle.


This process progressively shortens the extracellular collagen matrix at a rate up to 1 cm/month and stiffens the extracellular matrix through collagen crosslinking. The stiffened matrix transmits mechanical forces to adjacent tissues, which then undergo the same process. Under normal conditions, myofibroblast presence is temporary, limited by myofibroblast dedifferentiation or apoptosis triggered by loss of mechanical and cytokine stimulation. However, in DD, myofibroblasts persist through periods of diminished stimulation. The mechanism by which myofibroblasts resist apoptosis remains unknown.


It is believed that cords develop as a reactive process along lines of mechanical stress in susceptible tissues. The reason for individual susceptibility is unknown, but the profile of Dupuytren-type abnormalities found in phenotypically normal areas of palmar fascia prior to clinical disease include abnormally increased levels of type III collagen, abnormal mechanical stress–strain curves, abnormal tension-related contraction, DNA alterations, and some, but not all, Dupuytren-related gene expression markers.


Mechanical and gene expression characteristics of nodules, cords, and macroscopically normal palmar fascia in Dupuytren patients are all abnormal, but to different degrees. There is growing understanding of the biomechanics of fascial response to strain, age, and the cause-and-effect relationships of type III collagen to DD. The starting point could be the abnormal presence of type III collagen, mechanically different than type I, triggering abnormal mechanoregulatory stimulation of gene expression. Alternatively, the priming event might be abnormal mechanoregulation of gene activation resulting in overexpression of type III collagen.


Patterns of contracture may have more to do with collagen crosslinking than myofibroblast contraction. Some locations (i.e., distal palm, palmar digit) produce clinical contractures, but other common locations (i.e., DDN, Ledderhose) do not, despite the fact that biopsy tissue from each contracts similarly in vitro. A possible explanation is that Dupuytren biology fixes tissues in their resting position . The biology of collagen deposition and remodeling is activated by mechanical stress, but then continues during periods of rest. At rest, activated myofibroblasts and collagen crosslinking enzymes in the extracellular matrix shorten redundant collagen fibrils. At rest, this process remodels collagen length to match the resting dimension—similar to contracture of the PIP volar plate, which occurs after injury and prolonged flexion.


Such a process would be expected to produce contractures resembling the resting posture of the hand—flexion and adduction—which is what is seen in the vast majority of cases. It would also explain why knuckle pads and Ledderhose rarely develop contractures, because the IP joints rest in flexion and the metatarsophalangeal joints of the toes rest in extension.


Most patterns of DC can be explained as transformation of existing fascial structures through Luck’s stages into fibrous cords, guided by stress and stress shielding. In the process of cord formation, there is a reorientation of collagen fibers parallel to lines of mechanical stress. Any palmar fascial structure subjected to mechanical stress may contribute to Dupuytren cords. Stress shielding reduces the risk of contracture of certain locations, some of which have only minimal case reports of involvement. Structures rarely involved because of stress shielding include the Cleland ligament (shielded by adjacent phalanx); longitudinal fibers deep beneath the transverse superficial palmar ligament (shielded by the central band); transverse superficial palmar ligament (shielded by the transverse metacarpal ligament); and the septa of Legueu and Juvara (shielded by adjacent metacarpal). Stress shielding also provides the endpoint for disease progression.


As contractures progress, stress shielding from lack of use or from secondary capsuloligamentous joint contractures permanently removes mechanical stress from the cord; in the end, this allows myofibroblast apoptosis and progression to the final, involutional, static stage of disease.


Common cord patterns are shown in Figure 4.10 . Cords may be confined to the palm, the digit, or span both. Unlike cords that arise in the palm, cords isolated to a digit may have both proximal and distal bony attachments, making them more difficult to palpate.




FIGURE 4.10


Common cord patterns. A, Central digital, central palmar, distal first-web space, hypothenar, (B) lateral digital, (C) retrovascular, (D) spiral.


Common central palm cords are central palmar , spiral , and proximal first web . Common border palm cords are natatory , distal first web , hypothenar , and thenar . Thenar and hypo­thenar cords are uncommon and are usually associated with diffuse disease or aggressive biology. The majority of MCP joint contractures are a result of the effect of an isolated central cord. In contrast, the majority of PIP contractures are due to multiple digital cords , which, in order of frequency, are central digital , retrovascular , and spiral or lateral. Multiple cords can exist at the same longitudinal level in either palm or digit.


Secondary Pathology


Over time, flexed posture results in anatomic changes of joints and tendons independent of the causative cord. These issues are more likely to develop with more severe primary contractures. The PIP joint is particularly vulnerable to such changes. Contractures of the accessory collateral ligament are more common in PIP joint contractures greater than 45 degrees. Central slip attenuation contributes to extension deficit for PIP contractures greater than 60 degrees, which are less likely to achieve full correction than those with less severe contractures. Boutonnière, sagittal band rupture, or mallet deformity may develop secondary to chronic contractures. Sagittal band rupture can be difficult to diagnose in the context of a fixed MCP flexion contracture, but a key clue is MCP abduction–supination in the absence of a responsible palmar cord. Chronic rotational or lateral deformities from digital cords often persist after treatment of the primary disease.


Synergistic Pathology


Postural abnormalities from prior injury, chronic flexor tendinitis, osteoarthritis, peripheral neuropathy, intrinsic weakness, or mild spasticity are common in the senior demographic population and must be kept in mind in evaluation because they affect outcome expectations. Dupuytren disease is less common in rheumatoid patients, but it can coexist. This author has seen all of these conditions concurrent with DC, often not previously diagnosed.


Neurovascular Spiral Bundle


A neurovascular spiral bundle (i.e., spiral cord, or spiral nerve) is common in DC. Tissues that form a cord may initially describe a longitudinal path that spirals around a straight neurovascular bundle (see Figure 4.10 ). When this path tightens and straightens, the neurovascular bundle is displaced into a spiral path, raising a section of the bundle into a subcutaneous position that is superficial to the cord. If the neurovascular fat pad surrounding the bundle is displaced as well, this presents as an area where a palpable subdermal cord passes beneath a soft subcutaneous mass beneath soft skin. Such a finding is associated with a spiral bundle in the majority of cases, but lack of this finding is not predictive of absence of a spiral bundle.


Spiral bundles have been reported in nearly half of Dupuytren finger contractures. Superficial displacement is most common between the distal palmar crease and the flexion crease of the PIP joint. Variations occur, including cords that pass between the digital nerve and a dorsal branch, double spirals, and spirals at the level of the middle phalanx. Spiral bundles are at risk for inadvertent injury during open or percutaneous procedures.


Little Finger PIP Joint


Little finger PIP joint contractures have a worse prognosis and higher recurrence rate than other PIP joints, independent of surgical technique. Abductor digiti minimi (ADM) tendon involvement, common in little finger contractures, is not an independent risk factor for either inferior outcome or higher recurrence, and similar intrinsic tendon involvement can occur in any digit. ADM fascia involvement may explain loss of little finger supination frequently seen by this author with mild contractures.




Historical Review


Percutaneous fasciotomy and open fasciotomy were the most common procedures performed for DC in the early 1800s. Fasciectomy became the dominant procedure in the late 1800s, facilitated by the introduction of general anesthesia and then sterile technique. Radical fasciectomy, developed in the early 1900s, became the recommended procedure until the mid-1900s, when it became clear that it led to more morbidity but was not more effective. A trend to conservative treatment followed, paralleling development of minimally invasive techniques in all surgical specialties. Percutaneous needle fasciotomy and enzymatic fasciotomy, both pioneered in France during the mid-1900s, entered the mainstream of US practice in the early 2000s. As of this writing, fasciectomy is the most common procedure performed in the United States for DC, and by extension is the current standard of care. Additional historical data points are listed in Table 4.2 .



TABLE 4.2

Historical Points in the Treatment of Dupuytren Contracture








































































































Year Author Significance
1614 Plater Clinical description
1777 Cline Suggested fasciotomy
1822 Cooper Percutaneous fasciotomy
1831 Dupuytren Open fasciotomy
1834 Goyrand Fasciectomy
1875 Busch Open fasciotomy and skin graft
1906 Keen Radical fasciectomy
1908 Ombrédanne PIP arthrectomy for PIP contracture
1919 Griffith Fasciectomy and transposition flaps
1919 Davis Fasciectomy and full-thickness skin graft
1922 Eckstein Proximal phalanx-shortening osteotomy for PIP contracture
1931 Lexer Radical dermofasciectomy and full-thickness skin graft
1932 Palmén Fasciectomy and Y–V-plasty
1948 McIndoe Fasciectomy and Z-plasty
1957 De Seze and Debeyre Steroid injection and needle fasciotomy
1959 Luck Histologic staging
1963 Hueston Diathesis concept
1964 McCash Open palm technique
1965 Bassot Enzymatic fasciotomy with trypsin and other enzymes
1972 Gabbiani Myofibroblast identified in DC
1996 Moermans Segmental fasciectomy
2002 Agee Skeletal extension torque for PIP contractures
2009 Degreef Tamoxifen reduces recurrence after fasciectomy in high-risk patients
2010 Hurst and Badalamente CCH approved by FDA as contracture treatment

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 4, 2018 | Posted by in ORTHOPEDIC | Comments Off on Dupuytren Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access